Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.

Targeting colon cancer stem cells might lead to better treatment results.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Curcumin may be an effective and safer anticancer agent by regulating key cell pathways.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.